GGrantIndex
Sort

25,944 grants matching neurodegeneration

QUANTITATIVE MR IMAGING AND PROTON SPECTROSCOPY IN MS

$798,939
New York University School Of Medicine · R37 · FY2004 · NS

Explore roles of HSV-1 in Alzheimer's disease using mouse models

$798,803
Pinghui Feng · University Of Southern California · R01 · FY2022 · AG

Explore roles of HSV-1 in Alzheimer's disease using mouse models

$798,664
C Casey Chen · University Of Southern California · R01 · FY2021 · AG

Linking olfactory deficits to memory impairment and AD neurodegeneration

$798,633
Prasanna Rasika Karunanayaka · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2022 · AG

Development of targeted therapeutic agents for the treatment of FXTAS (2 of 6)

$798,611
Paul J Hagerman · University Of California At Davis · RL1 · FY2010 · AG

Insulin Receptor Structure and Turnover

$798,527
C Ronald Kahn · Joslin Diabetes Center · R37 · FY2010 · DK

Microglia-Amyloid interactions in delirium superimposed on dementia

$798,413
Niccolo Terrando · Duke University · R01 · FY2025 · AG

Neurodegeneration and Brain Function in Aging with HIV and Parkinson's Disease

$798,305
Tilman Schulte · Sri International · R01 · FY2016 · AA

Validating remote digital assessments for familial frontotemporal dementia

$798,073
Adam Mark Staffaroni · University Of California, San Francisco · R01 · FY2025 · AG

Gut-brain axis in Alzheimer's disease: translational 7T MRI markers and underlying mechanisms

$797,809
Ai-Ling Lin · University Of Missouri-Columbia · R56 · FY2024 · AG

Identifying distinct tau polymorphs in Alzheimer’s disease and development of early diagnostics for aggregation of tau polymorphs

$797,318
David Eisenberg · University Of California Los Angeles · R56 · FY2018 · AG

Randomized Comparison of the Clinical Outcome of Single Versus Multiple Arterial Grafts: Cognition (ROMA:Cog)

$797,244
Ruth Marie Masterson Creber · Columbia University Health Sciences · R01 · FY2023 · NS

Amyloid-Beta Oligomer Selective Immunotherapy for Prodromal or Mild Alzheimer Disease

$797,087
Eric Siemers · Acumen Pharmaceuticals, Inc. · U01 · FY2020 · AG

Optimization of a potent and cell active CK2 chemical probe for Alzheimer's disease therapy

$796,443
Alison Donnelly Axtman · Univ Of North Carolina Chapel Hill · R56 · FY2025 · AG

Mitochondrial Stress Response in FUS proteinopathy and related dementia

$796,399
John A Kessler · Northwestern University At Chicago · R56 · FY2019 · AG

Discovering novel players in mechanisms of extracellular vesicle release, cargo loading, and early pathogenesis of late-onset Alzheimer's Disease

$796,284
Kenneth W Witwer · Johns Hopkins University · R56 · FY2017 · AG

Training in the Molecular Biology of Neurodegeneration and Alzheimer's Disease

$796,164
Bruce A Yankner · Harvard Medical School · T32 · FY2017 · AG

Characterization of relationship between tau pathology and neurodegeneration in Alzheimer's disease using multimodal imaging

$796,113
Sandhitsu Das · University Of Pennsylvania · R01 · FY2024 · AG

Alzheimer's Disease Hallmark Pathology and Associated Inflammation in the Retina

$796,050
Maya Koronyo-Hamaoui · Cedars-Sinai Medical Center · R01 · FY2025 · AG

Emotion alterations across the Alzheimer's disease spectrum

$795,963
Virginia Emily Sturm · University Of California, San Francisco · R01 · FY2023 · AG

CNS sirtuins in radiation-induced vascular permeability and neurodegeneration

$795,711
Deedee Smart · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Clinical Core

$795,625
Christopher H Van Dyck · Yale University · P30 · FY2020 · AG

mRNA Translation, TOR and Geroscience (2 of 11)

$795,400
Pankaj Kapahi · Buck Institute For Research On Aging · RL1 · FY2009 · AG

Brain Vascularity in Cardiac Surgery &Neurodegeneration

$795,382
Wake Forest University Health Sciences · R01 · FY2004 · NS

A bidirectional deep brain interface to unravel the pathogenic role of vascular amyloid in Alzheimer's disease

$795,315
Song Hu · Washington University · R56 · FY2023 · AG